A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Methodist Health System
- Enrollment
- 504
- Locations
- 1
- Primary Endpoint
- Morbidity and length of stay
Overview
Brief Summary
The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
Detailed Description
Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Plan to perform a retrospective review of management protocols at these institutions. Wish to know whether the implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
The objective of the study is to review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress.
Hypothesize that implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 89 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •• Adults aged 18-89 years of age
- •Patients presenting with SBO
Exclusion Criteria
- •• Prisoners
- •Pregnant women
Outcomes
Primary Outcomes
Morbidity and length of stay
Time Frame: 1 year
Morbidity and length of stay
Secondary Outcomes
- Aspirin(ASA )class(1 year)
- time of contrast given(1 year)
- admit date(1 year)
- comorbidities(1 year)
- labs(1 year)
- Patient demographics(1 year)
- discharge date(1 year)
- admission service(1 year)
- surgical history(1 year)